Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 142 clinical trials for: 150 miles

Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
  • Recruiting
NCT07144280
Sex: All
Age: 18+
Locations: 159
View study
Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
  • Recruiting
NCT06807268
Sex: All
Age: 6 - 11
Locations: 39
View study
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
  • Recruiting
NCT06952660
Sex: Female
Age: 18+
Locations: 50
View study
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
  • Recruiting
NCT06758401
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
  • Recruiting
NCT06679140
Sex: All
Age: 12+
Locations: 234
View study
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  • Recruiting
NCT06629779
Sex: Male
Age: 18+
Locations: 240
View study
Recruiting
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
  • Recruiting
NCT07013474
Sex: All
Age: 18+
Locations: 117
View study
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
  • Recruiting
NCT06616194
Sex: All
Age: 12 - 17
Locations: 109
View study
Recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
  • Recruiting
NCT06966453
Sex: All
Age: 18+
Locations: 159
View study
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
  • Recruiting
NCT07028853
Sex: Male
Age: 18+
Locations: 188
View study
...